Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Oct 1.

Published in final edited form as: Antiviral Res. 2021 Aug 9;194:105160. doi: 10.1016/j.antiviral.2021.105160

Figure 3. — Histograms show optimization results of: (A) KOS6β infection and (B) dlx3.1-6β infection. For each reporter virus the data compares: 1% or 2% FBS, MOIs: 0, 0.2, 1, and 5, and β-galactosidase levels at 6 hpi, 12 hpi, and 24 hpi using CPRG, and assay stability from 5 to 1080 minutes.

Figure 3. — Histograms show optimization results of: (A) KOS6β infection and (B) dlx3.1-6β infection. For each reporter virus the data compares: 1% or 2% FBS, MOIs: 0, 0.2, 1, and 5, and β-galactosidase levels at 6 hpi, 12 hpi, and 24 hpi using CPRG, and assay stability from 5 to 1080 minutes.